20
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Choice of baseline in a multiple-dose thorough QT study (TQTS) – effect on analysis of moxifloxacin-induced QTc prolongation

, , , , &
Pages 1-7 | Published online: 22 Dec 2009

References

  • Dessertenne F. Ventricular tachycardia with 2 variable opposing foci. Arch Mal Coeur Vaiss. 1966;59(2):263–272.
  • Wang SH, Lin CY, Huang TY, Wu WS, Chen CC, Tsai SH. QT interval effects of cisapride in the clinical setting. Int J Cardiol. 2001;80(2–3):179–183.
  • Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350(10):1013–1022.
  • Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003;89(11):1363–1372.
  • Roden DM, Anderson ME. The pause that refreshes, or does it? Mechanisms in torsades de pointes. Heart. 2000;84(3):235–237.
  • ICH Topic E 14 The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. 2005; [Accessed September, 2009] Available from: http://www.emea.europa.eu/pdfs/human/ich/000204en.pdf.
  • Marfella R, Gualdiero P, Siniscalchi M, et al. Morning blood pressure peak, QT intervals, and sympathetic activity in hypertensive patients. Hypertension. 2003;41(2):237–243.
  • Yee KM, Pringle SD, Struthers AD. Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure. J Am Coll Cardiol. 2001;37(7):1800–1807.
  • Molnar J, Ranade V Cvetanovic I, Molnar Z, Somberg JC. Evaluation of a 12-lead digital Holter system for 24-hour QT interval assessment. Cardiology. 2006;106(4):224–232.
  • Nagy D, DeMeersman R, Gallagher D, et al. QTc interval (cardiac repolarization): lengthening after meals. Obes Res. 1997;5(6):531–537.
  • Williams GC, Dunnington KM, Hu MY, et al. The impact of posture on cardiac repolarization: more than heart rate? J Cardiovasc Electrophysiol. 2006;17(4):352–358.
  • Health Canada Guidance Document. Guide for the Analysis and Review of QT/QTc Interval Data. [Accessed September 2009] Available from: http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/prodpharma/qt_review_examen-eng.pdf.
  • Bloomfield DM, Kost JT, Ghosh K, et al. The effect of moxifloxacin on QTc and implications for the design of thorough QT studies. Clin Pharmacol Ther 2008;84(4):475–480.
  • Zhang X, Silkey M, Schumacher M, et al. Period correction of the QTc of moxifloxacin with multiple predose baseline ECGs is the least variable of 4 methods tested. J Clin Pharmacol 2009;49(5):534–539.
  • Badilini F, Maison-Blanche P, Childers R, Coumel P. QT interval analysis on ambulatory electrocardiogram recordings: a selective beat averaging approach. Med Biol Eng Comput. 1999;37(1):71–79.
  • Kligfield P, Tyl B, Maarek M, Maison-Blanche P. Magnitude, mechanism, and reproducibility of QT interval differences between superimposed global and individual lead ECG complexes. Ann Noninvasive Electrocardiol. 2007;12(2):145–152.
  • Fridericia LS. The duration of systole in an electrocardiogram in normal humans and in patients with heart disease. 1920. Ann Noninvasive Electrocardiol. 2003;8(4):343–351.
  • Malik M, Farbom P, Batchvarov V, Hnatkova K, Camm AJ. Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval. Heart. 2002;87(3):220–228.
  • Malik M, Hnatkova K, Batchvarov V, Gang Y, Smetana P, Camm AJ. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation. Pacing Clin Electrophysiol. 2004;27(12):1659–1669.
  • Couderc JP, Xiaojuan X, Zareba W, Moss AJ. Assessment of the stability of the individual-based correction of QT interval for heart rate. Ann Noninvasive Electrocardiol. 2005;10(1):25–34.
  • Garnett CE, Beasley N, Bhattaram VA, et al. Concentration-QT relationships play a key role in the evaluation of proarrhythmic risk during regulatory review. J Clin Pharmacol. 2008;48(1):13–18.
  • E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. Questions and Answers. 2008; [Accessed September 2009] Available at http://www.emea.europa.eu/pdfs/human/ich/31013308en.pdf.
  • Diedrich A, Jordan J, Shannon JR, Robertson D, Biaggioni I. Modulation of QT interval during autonomic nervous system blockade in humans. Circulation. 2002;106(17):2238–2243.
  • Ong JJ, Sarma JS, Venkataraman K, Levin SR, Singh BN. Circadian rhythmicity of heart rate and QTc interval in diabetic autonomic neuropathy: implications for the mechanism of sudden death. Am Heart J. 1993;125(3):744–752.
  • Journal article on the Internet: The European Agency for the Evaluation of Medicinal Products (EMEA), committee for Proprietary Medicinal Products (CPMP), Efficacy Working Party (EXP). Points to consider on adjustment for baseline covariates.[Accessed 2009]. http://www.emea.europa.eu/pdfs/human/ewp/286399en.pdf
  • Senn SJ. Cross-over trials in clinical research. 2nd ed. Chichester: Willey; 2002.
  • Extramiana F, Maison-Blanche P, Haggui A, Badilini F, Beaufils P, Leenhardt A. Control of rapid heart rate changes for electrocardiographic analysis: implications for thorough QT studies. Clin Cardiol. 2006;29(12):534–539.
  • Zhang J, Machado SG. Statistical issues including design and sample size calculation in thorough QT/QTc studies. J Biopharm Stat. 2008;18(3):451–67.